Class IIOngoingD-0235-2026
Drug recall · December 24, 2025
Baclofen Tablets USP recall
Why: Presence of Foreign Tablets/Capsules
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Baclofen Tablets USP, 10 mg, 1000-count bottles, Rx only, Marketed by: GSMS, Incorporated, CA 93012 USA. NDC 51407-973-10
- Lots / codes
Lot GS065762
- Quantity
- 2472 HDPE Bottles
- Company
- Golden State Medical Supply Inc., Camarillo, CA
- Distribution
- Nationwide within the USA
- Initiated
- November 26, 2025 · Voluntary: Firm initiated
- Classified
- December 15, 2025
- Reported
- December 24, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Baclofen
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.